Global Coalition for Adaptive Research
Rob Murray has a strong background in business development and clinical services. Rob currently serves as the Chief Business Officer for the Global Coalition for Adaptive Research, where they oversee development strategies and partnerships. Prior to this, they worked at Novella Clinical, Inc. for over 16 years in various roles, including Vice President of Global Head Business Development, Oncology and Biopharma. Rob also has experience as a Director of Clinical Client Services at Novella Clinical and as a Senior Clinical Research Associate at PharmaLinkFHI, Inc. and PPD.
Rob Murray earned a Bachelor of Science degree in Biology and Chemistry from the University of North Carolina at Chapel Hill, which they attended from 1991 to 1996. Rob also completed their Master of Business Administration (MBA) in Business Administration from UOPHX from 2001 to 2003. Prior to their higher education, Rob attended Bay Shore High School.
This person is not in any offices
Global Coalition for Adaptive Research
The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved.